company background image
ECS logo

ECS Botanics Holdings CHIA:ECS Stock Report

Last Price

AU$0.017

Market Cap

AU$21.3m

7D

13.3%

1Y

-22.7%

Updated

21 Jan, 2025

Data

Company Financials

ECS Botanics Holdings Ltd

CHIA:ECS Stock Report

Market Cap: AU$21.3m

ECS Stock Overview

Engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria. More details

ECS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Rewards

Price-To-Earnings ratio (11.1x) is below the Australian market (19.3x)

Earnings grew by 289.8% over the past year

Risk Analysis

High level of non-cash earnings

Does not have a meaningful market cap (A$21M)

Volatile share price over the past 3 months compared to the Australian market

Shareholders have been diluted in the past year


My Notes

Capture your thoughts, links and company narrative

ECS Botanics Holdings Ltd Competitors

Vitura Health

ASX:VIT

AU$47.1m

Vita Life Sciences

ASX:VLS

AU$111.3m

Neuren Pharmaceuticals

ASX:NEU

AU$1.7b

NeuroScientific Biopharmaceuticals

ASX:NSB

AU$5.6m

Price History & Performance

Summary of share price highs, lows and changes for ECS Botanics Holdings
Historical stock prices
Current Share PriceAU$0.017
52 Week HighAU$0.029
52 Week LowAU$0.013
Beta1.28
1 Month Change6.25%
3 Month Change0%
1 Year Change-22.73%
3 Year Change-41.38%
5 Year Change-65.31%
Change since IPO-74.24%

Recent News & Updates

Recent updates

Shareholder Returns

ECSAU PharmaceuticalsAU Market
7D13.3%3.9%2.1%
1Y-22.7%-5.2%10.1%

Return vs Industry: ECS underperformed the Australian Pharmaceuticals industry which returned -8.4% over the past year.

Return vs Market: ECS underperformed the Australian Market which returned 9.7% over the past year.

Price Volatility

Is ECS's price volatile compared to industry and market?
ECS volatility
ECS Average Weekly Movement12.4%
Pharmaceuticals Industry Average Movement9.2%
Market Average Movement7.9%
10% most volatile stocks in AU Market16.4%
10% least volatile stocks in AU Market2.9%

Stable Share Price: ECS's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: ECS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
n/an/aNan-Maree Schoeriewww.ecs-botanics.com

ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria. The company is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.

ECS Botanics Holdings Ltd Fundamentals Summary

How do ECS Botanics Holdings's earnings and revenue compare to its market cap?
ECS fundamental statistics
Market capAU$21.26m
Earnings (TTM)AU$1.92m
Revenue (TTM)AU$20.03m

11.1x

P/E Ratio

1.1x

P/S Ratio

Is ECS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ECS income statement (TTM)
RevenueAU$20.03m
Cost of RevenueAU$12.52m
Gross ProfitAU$7.51m
Other ExpensesAU$5.60m
EarningsAU$1.92m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.0015
Gross Margin37.51%
Net Profit Margin9.56%
Debt/Equity Ratio0%

How did ECS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 10:02
End of Day Share Price 2025/01/21 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ECS Botanics Holdings Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stuart RobertsPitt Street Research Pty Ltd.